Literature DB >> 23818020

Preventing brain atrophy should be the gold standard of effective therapy in multiple sclerosis (after the first year of treatment): Commentary.

D L Arnold1, N De Stefano.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23818020     DOI： 10.1177/1352458513490550

Source DB:  PubMed          Journal:  Mult Scler        ISSN： 1352-4585            Impact factor:   6.312


× No keyword cloud information.
  5 in total

Review 1.  Clinical relevance of brain volume measures in multiple sclerosis.

Authors:  Nicola De Stefano; Laura Airas; Nikolaos Grigoriadis; Heinrich P Mattle; Jonathan O'Riordan; Celia Oreja-Guevara; Finn Sellebjerg; Bruno Stankoff; Agata Walczak; Heinz Wiendl; Bernd C Kieseier
Journal:  CNS Drugs       Date:  2014-02       Impact factor: 5.749

Review 2.  The importance of studying sex differences in disease: The example of multiple sclerosis.

Authors:  Lisa C Golden; Rhonda Voskuhl
Journal:  J Neurosci Res       Date:  2017-01-02       Impact factor: 4.164

Review 3.  The effect of disease modifying therapies on brain atrophy in patients with relapsing-remitting multiple sclerosis: a systematic review and meta-analysis.

Authors:  Georgios Tsivgoulis; Aristeidis H Katsanos; Nikolaos Grigoriadis; Georgios M Hadjigeorgiou; Ioannis Heliopoulos; Constantinos Kilidireas; Konstantinos Voumvourakis
Journal:  PLoS One       Date:  2015-03-10       Impact factor: 3.240

4.  Correlation between brain volume change and T2 relaxation time induced by dehydration and rehydration: implications for monitoring atrophy in clinical studies.

Authors:  Kunio Nakamura; Robert A Brown; David Araujo; Sridar Narayanan; Douglas L Arnold
Journal:  Neuroimage Clin       Date:  2014-08-23       Impact factor: 4.881

5.  The Effect of Disease-Modifying Drugs on Brain Atrophy in Relapsing-Remitting Multiple Sclerosis: A Meta-Analysis.

Authors:  Pierre Branger; Jean-Jacques Parienti; Maria Pia Sormani; Gilles Defer
Journal:  PLoS One       Date:  2016-03-16       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.